Company intelligence / Profile preview

EpiEP

New Haven, Connecticut, United Statesepiep.com ↗

Ownership: Private
Development stage: Commercial

Overview

The EpiAccess™ System has received both FDA clearance and CE marking. Clinical feedback indicates physician satisfaction with its performance in providing real-time guidance during epicardial access procedures. The system's unique pressure-guided needle offers adjunctive data to help physicians safely enter the pericardial space.

No specific clinical trial results are detailed in public sources, but pre-clinical and clinical use have been reported as successful by users.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Drug pipeline

1 asset

EpiAccess

Commercial

Indications: Cardiac arrhythmia

Beyond the preview

Go deeper on EpiEP.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EpiEP.

Explore the full profile